|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Y, Feng Y, Gao Y and Hou R: Clinical
benefits of combined chemotherapy with S-1, oxaliplatin, and
docetaxel in advanced gastric cancer patients with palliative
surgery. Onco Targets Ther. 9:1269–1273. 2016.PubMed/NCBI
|
|
3
|
Pecqueux M, Fritzmann J, Adamu M, Thorlund
K, Kahlert C, Reißfelder C, Weitz J and Rahbari NN: Free
intraperitoneal tumor cells and outcome in gastric cancer patients:
A systematic review and meta-analysis. Oncotarget. 6:35564–35578.
2015.PubMed/NCBI
|
|
4
|
Xu P and Derynck R: Direct activation of
TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF
receptor-dependent cell proliferation. Mol Cell. 37:551–566. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang TC, Zhu WG, Huang MD, Fan RH and
Chen XF: Prognostic value of ADAM17 in human gastric cancer. Med
Oncol. 29:2684–2690. 2012. View Article : Google Scholar
|
|
6
|
Kenny PA and Bissell MJ: Targeting
TACE-dependent EGFR ligand shedding in breast cancer. J Clin
Invest. 117:337–345. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Szalad A, Katakowski M, Zheng X, Jiang F
and Chopp M: Transcription factor Sp1 induces ADAM17 and
contributes to tumor cell invasiveness under hypoxia. J Exp Clin
Cancer Res. 28:1292009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yoshimura T, Tomita T, Dixon MF, Axon AT,
Robinson PA and Crabtree JE: ADAMs (a disintegrin and
metalloproteinase) messenger RNA expression in Helicobacter
pylori-infected, normal, and neoplastic gastric mucosa. J Infect
Dis. 185:332–340. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yasuda H, Hirata S, Inoue K, Mashima H,
Ohnishi H and Yoshiba M: Involvement of membrane-type bile acid
receptor M-BAR/TGR5 in bile acid-induced activation of epidermal
growth factor receptor and mitogen-activated protein kinases in
gastric carcinoma cells. Biochem Biophys Res Commun. 354:154–159.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ebi M, Kataoka H, Shimura T, Kubota E,
Hirata Y, Mizushima T, Mizoshita T, Tanaka M, Mabuchi M, Tsukamoto
H, et al: TGFβ induces proHB-EGF shedding and EGFR transactivation
through ADAM activation in gastric cancer cells. Biochem Biophys
Res Commun. 402:449–454. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tape CJ, Willems SH, Dombernowsky SL,
Stanley PL, Fogarasi M, Ouwehand W, McCafferty J and Murphy G:
Cross-domain inhibition of TACE ectodomain. Proc Natl Acad Sci USA.
108:5578–5583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richards FM, Tape CJ, Jodrell DI and
Murphy G: Anti-tumour effects of a specific anti-ADAM17 antibody in
an ovarian cancer model in vivo. PLoS One. 7:e405972012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang L, Wu RL and Xu AM:
Epithelial-mesenchymal transition in gastric cancer. Am J Transl
Res. 7:2141–2158. 2015.
|
|
15
|
Savagner P: Epithelial-mesenchymal
transitions: From cell plasticity to concept elasticity. Curr Top
Dev Biol. 112:273–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng H and Kang Y: Multilayer control of
the EMT master regulators. Oncogene. 33:1755–1763. 2014. View Article : Google Scholar
|
|
18
|
Duffy MJ, Mullooly M, O’Donovan N, Sukor
S, Crown J, Pierce A and McGowan PM: The ADAMs family of proteases:
New biomarkers and therapeutic targets for cancer? Clin Proteomics.
8:92011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu B, Sha L, Wang Y, Xu W, Yu Y, Feng F,
Sun C and Xia L: Diagnostic and prognostic value of a disintegrin
and metalloproteinase-17 in patients with gliomas. Oncol Lett.
8:2616–2620. 2014.PubMed/NCBI
|
|
20
|
Cai M, Wang Z, Zhang J, Zhou H, Jin L, Bai
R and Weng Y: Adam17, a target of mir-326, promotes EMT-induced
cells invasion in lung adenocarcinoma. Cell Physiol Biochem.
36:1175–1185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Van Schaeybroeck S, Kalimutho M, Dunne PD,
Carson R, Allen W, Jithesh PV, Redmond KL, Sasazuki T, Shirasawa S,
Blayney J, et al: ADAM17-dependent c-MET-STAT3 signaling mediates
resistance to MEK inhibitors in KRAS mutant colorectal cancer. Cell
Rep. 7:1940–1955. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shou ZX, Jin X and Zhao ZS: Upregulated
expression of ADAM17 is a prognostic marker for patients with
gastric cancer. Ann Surg. 256:1014–1022. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tennakoon AH, Izawa T, Kuwamura M and
Yamate J: Pathogenesis of type 2 epithelial to mesenchymal
transition (EMT) in renal and hepatic fibrosis. J Clin Med.
5:52015. View Article : Google Scholar
|
|
24
|
Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K,
Kim TJ, Ham J, Jang HJ, Kang KS and Ko H: Stereospecific effects of
ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal
transition and suppresses lung cancer migration, invasion and
anoikis resistance. Toxicology. 322:23–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesenchymal transition in mammary epithelial cells is
mediated by NF-κB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Q, Zheng X, Chen L, Xu B, Yang X,
Jiang J and Wu C: Smad2/3/4 pathway contributes to TGF-beta-induced
MiRNA-181b Expression to promote gastric cancer metastasis by
targeting Timp3. Cell Physiol Biochem. 39:453–466. 2016. View Article : Google Scholar
|
|
27
|
Zimmerman KA, Xing D, Pallero MA, Lu A,
Ikawa M, Black L, Hoyt KL, Kabarowski JH, Michalak M and
Murphy-Ullrich JE: Calreticulin regulates neointima formation and
collagen deposition following carotid artery ligation. J Vasc Res.
52:306–320. 2015. View Article : Google Scholar
|
|
28
|
Huang P, Zhang Y, Jiang T and Zhang N:
Effects of p38 MAPK signaling pathway and aldose reductase on
transforming growth factor-beta1 induced expression of fibronectin
in cultured human mesangial cells. Zhonghua Bing Li Xue Za Zhi.
44:778–782. 2015.(In Chinese).
|
|
29
|
Tennant BR, Chen J, Shih AZ, Luciani DS
and Hoffman BG: Myt3 mediates laminin-V/integrin-β1-induced
islet-cell migration via Tgfbi. Mol Endocrinol. 29:1254–1268. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hirunsai M, Srikuea R and Yimlamai T: Heat
stress promotes extracellular matrix remodelling via TGF-beta1 and
MMP-2/TIMP-2 modulation in tenotomised soleus and plantaris
muscles. Int J Hyperthermia. 31:336–348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao J, Cheng Q, Ye P, Yang G, Liu S, Ao
Q, Liu Y and Hu Y: Atorvastatin improves pathological changes in
the aged kidney by upregulating peroxisome proliferator-activated
receptor expression and reducing matrix metalloproteinase-9 and
transforming growth factor-β1 levels. Exp Gerontol. 74:37–42. 2016.
View Article : Google Scholar
|
|
32
|
Weskamp G, Mendelson K, Swendeman S, Le
Gall S, Ma Y, Lyman S, Hinoki A, Eguchi S, Guaiquil V, Horiuchi K,
et al: Pathological neovascularization is reduced by inactivation
of ADAM17 in endothelial cells but not in pericytes. Circ Res.
106:932–940. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu Y, Jiang F, Zheng X, Katakowski M,
Buller B, To SS and Chopp M: TGF-β1 promotes motility and
invasiveness of glioma cells through activation of ADAM17. Oncol
Rep. 25:1329–1335. 2011.PubMed/NCBI
|
|
34
|
Song J: EMT or apoptosis: A decision for
TGF-beta. Cell Res. 17:289–290. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang Y, Zhu F, Zhang H, Chen D, Zhang X,
Gao Q and Li Y: Conditional ablation of TGF-β signaling inhibits
tumor progression and invasion in an induced mouse bladder cancer
model. Sci Rep. 6:294792016. View Article : Google Scholar
|
